Hycor Biomedical is proud to present a new video presenting the NOVEOS analyzer

NOVEOS® DESIGNED WITH YOUR LAB IN MIND

Using extensive input from labs and clinicians around the world, the allergy-focused design brings unmatched competitive advantages. The NOVEOS system requires only 4-μL sample size per test which reduce quantity not sufficient errors, resampling and patient trauma. The advanced micro-particle technology limits interference from: Biotin, IgG / IgG4, and Solid-phase related cross-reactive carbohydrate determinant (CCD). The small sample volume per test leads to less interference from serum-based substances. The microparticle approach gives a dramatic increase in surface area leading to superb sensitivity, excellent low-end precision and operates up to 13 hours of true walk-away capability for laboratory technicians.

• Highly automated instrument with a full walk-away capability

• Liquid, ready-to-use reagents allowing much larger lot sizes

• Cutting-edge immunochemistry for high sensitivity and an excellent low-end precision delivers actionable, reliable results for better clinical decisions

• The intuitive user interface allows for ease of training and routine operation

• Using only 4 µL sample per test whereas competitor systems need 40-50 µL per test

The 4-μL Sample Size is a Breakthrough!

Significant reduction in sample size helps your lab focus on testing, not sample management NOVEOS not only runs more allergy tests and more follow-up tests per tube, it also reduces additional blood draws. The small sample volume also reduces the need for test prioritization by clinicians and laboratorians. Testing for more allergens using less sample benefits patients and labs. It may seem small, but for pediatric patients and their families, it’s a major upgrade.